Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GeneDx Holdings (WGSWW) Gross Profit (2020 - 2025)

GeneDx Holdings has reported Gross Profit over the past 6 years, most recently at $84.3 million for Q4 2025.

  • Quarterly results put Gross Profit at $84.3 million for Q4 2025, up 27.28% from a year ago — trailing twelve months through Dec 2025 was $298.2 million (up 53.38% YoY), and the annual figure for FY2025 was $298.2 million, up 53.38%.
  • Gross Profit for Q4 2025 was $84.3 million at GeneDx Holdings, roughly flat from $84.5 million in the prior quarter.
  • Over the last five years, Gross Profit for WGSWW hit a ceiling of $84.5 million in Q3 2025 and a floor of -$29.6 million in Q2 2022.
  • Median Gross Profit over the past 5 years was $22.0 million (2023), compared with a mean of $27.0 million.
  • Biggest five-year swings in Gross Profit: tumbled 2442.78% in 2022 and later soared 288.37% in 2023.
  • GeneDx Holdings' Gross Profit stood at -$2.8 million in 2021, then crashed by 481.82% to -$16.3 million in 2022, then soared by 288.37% to $30.8 million in 2023, then skyrocketed by 115.27% to $66.2 million in 2024, then grew by 27.28% to $84.3 million in 2025.
  • The last three reported values for Gross Profit were $84.3 million (Q4 2025), $84.5 million (Q3 2025), and $70.9 million (Q2 2025) per Business Quant data.